The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNichols plc Regulatory News (NICL)

Share Price Information for Nichols plc (NICL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 994.00
Bid: 970.00
Ask: 998.00
Change: -4.00 (-0.40%)
Spread: 28.00 (2.887%)
Open: 966.00
High: 998.00
Low: 966.00
Prev. Close: 998.00
NICL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

11 Jan 2023 07:00

RNS Number : 3099M
Nichols PLC
11 January 2023
 

11 January 2023

Nichols plc

(the "Company" or "Group')

Trading Update

Nichols plc, the diversified soft drinks Group, provides the following trading update for the 12 months to 31 December 2022 ("the Period").

Total Group revenue during the year increased by +14%1 to £164.9m1, with second half performance up +10%1 year-on-year.

The Vimto brand continued to perform well, with its brand value increasing by +3.4% in the UK, according to Nielsen2 as at 3 December 2022. This is broadly in line with the performance of the Group's UK packaged route to market. 

In the International packaged route to market, the Vimto brand continued to see strong progress year-on-year, with revenue growth +15%1 versus the prior year. Second half performance was +48%1 up year-on-year, with positive performance in all regions.

The Group's Out of Home ("OoH") route to market continues to recover from the impact of the pandemic and has seen revenue growth of +43%1 year-on-year. H2 growth slowed to +5%1, reflecting a more normalised trading environment in the prior year comparative period, as well as the widely publicised cost of living pressures. The outcome of the Group's OoH Strategic Review will be announced with the Preliminary Results in March 2023, where significant opportunities for net margin improvement have been identified. Actions are expected to be implemented throughout FY23, with benefits being realised from FY24.

Despite ongoing inflationary pressures, which accelerated during the second half, the Group expects to report FY22 Adjusted Profit Before Tax ("Adjusted PBT")3 in line with market expectations.

Cash generation remained strong throughout 2022, and cash and cash equivalents at the end of the year stood at £56.3m1 (31 December 2021: £56.7m).

Chair succession

Nichols plc also today announces the appointment of Elizabeth McMeikan as its next Non-Executive Chair. More information on Elizabeth's appointment can be found in the separate announcement issued to the London Stock Exchange today.

Outlook

The Group has a proven, diversified, and international business model. However, it is not immune to the significant and accelerating inflationary pressures impacting the wider consumer and soft drinks markets. Whilst FY23 will be a challenging year as cost of living pressures impact consumer demand across all routes to market, the Group will continue to seek to mitigate these pressures through both cost efficiency and revenue management. Throughout FY22, this has helped the Vimto brand continue to grow in the UK and Internationally, which the Board is confident will continue in FY23.

The Board currently expects FY23 Adjusted PBT to be broadly in line with FY22 but remains confident of significant progress in FY24 as inflationary pressures abate and the benefits of the OoH Strategic Review are realised.

With a long-term track record of growth, a proven and diversified strategy, a quality range of brands and a strong balance sheet, the Board remains highly confident that the Group is very well positioned to deliver its long-term growth plans.

The Group intends to announce its 2022 Preliminary Results on 1 March 2023.

1 Unaudited

2 Source: Nielsen IQ RMS data for the Total Soft Drinks category for the YTD ending 3 December 2022 for the GB Total Coverage market

3 Excluding Exceptional items

Contacts

 

Nichols plc

Andrew Milne, Group Chief Executive Officer

David Rattigan, Group Chief Financial Officer

Telephone: 0192 522 2222

Singer Capital Markets (NOMAD & Broker)

Steve Pearce / Jen Boorer 

Telephone: 0207 496 3000

Website: www.singercm.com

Hudson Sandler (Financial PR)

Alex Brennan / Charlotte Cobb / Harry Griffiths

Telephone: 0207 796 4133

Email: nichols@hudsonsandler.com

 

Notes to Editors:

Nichols plc is an international diversified soft drinks business with sales in over 73 countries, selling products in both the Still and Carbonate categories. The Group is home to the iconic Vimto brand which is popular in the UK and around the world, particularly in the Middle East and Africa. Other brands in its portfolio include SLUSH PUPPiE, Feel Good, Starslush, ICEE, Levi Roots and Sunkist.

For more information about Nichols, visit: www.nicholsplc.co.uk

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKBLFFXFLFBBV
Date   Source Headline
26th Apr 20242:15 pmRNSGrant of SAYE Options & PDMR Dealings
25th Apr 202411:00 amRNSResult of Annual General Meeting 2024
24th Apr 20247:00 amRNSAGM Trading Update
19th Apr 20242:00 pmRNSExercise of Share Options & Total Voting Rights
11th Apr 20245:53 pmRNSDirector / PDMR Dealing and Total Voting Rights
28th Mar 20243:15 pmRNSPublication of Annual Report & Notice of AGM
27th Mar 20247:00 amRNSGrant of Options & PDMR Dealings
6th Mar 20247:00 amRNS2023 Preliminary Results
29th Feb 20247:00 amRNSNotice of Results and Investor Presentation
10th Jan 20247:00 amRNSFY23 Trading Update and Appointment of NED
27th Nov 20233:07 pmRNSHolding(s) in Company
21st Nov 20234:36 pmRNSHolding(s) in Company
25th Oct 20237:00 amRNSAppointment of CFO and NED Change
25th Sep 20234:57 pmRNSHolding(s) in Company
11th Sep 20234:26 pmRNSDirector/PDMR Shareholding
24th Aug 20235:57 pmRNSDirector/PDMR Shareholding
26th Jul 20237:00 amRNS2023 Interim Results
13th Jul 20237:00 amRNSNotice of Results and Investor Presentation
21st Jun 20237:00 amRNSAppointment of Interim CFO
26th May 20233:51 pmRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSGrant of Options and PDMR Dealings
27th Apr 20233:09 pmRNSGrant of SAYE Options and PDMR Dealings
26th Apr 20233:11 pmRNSResult of Annual General Meeting 2023
26th Apr 20237:00 amRNSAGM Trading Update and Board Changes
21st Apr 20234:57 pmRNSCancellation of SAYE Options & PDMR Dealings
29th Mar 20233:10 pmRNSPublication of Annual Report and Notice of AGM
23rd Mar 20232:42 pmRNSDirector/PDMR Shareholding
1st Mar 20239:17 amRNS2022 Preliminary Results - Correction
1st Mar 20237:00 amRNS2022 Preliminary Results
20th Feb 20237:00 amRNSNotice of Investor Presentation
11th Jan 20237:00 amRNSAppointment of Non-Executive Chair
11th Jan 20237:00 amRNSTrading Update
7th Sep 202211:05 amRNSHolding(s) in Company
27th Jul 20227:00 amRNS2022 Interim Results
8th Jul 20227:00 amRNSNotice of Results and Investor Presentation
17th Jun 20222:52 pmRNSDirector/PDMR Shareholding
9th Jun 20225:27 pmRNSDirector/PDMR Shareholding
18th May 20221:18 pmRNSDirector/PDMR Shareholding
6th May 20224:41 pmRNSSecond Price Monitoring Extn
6th May 20224:35 pmRNSPrice Monitoring Extension
28th Apr 20221:54 pmRNSGrant of SAYE Options and PDMR Dealings
27th Apr 20221:48 pmRNSResult of AGM
27th Apr 20227:00 amRNSAGM Trading Update and Chairman Succession
6th Apr 20227:00 amRNSCompletion of Share Buyback
5th Apr 202212:10 pmRNSPurchase of Own Shares
4th Apr 202210:47 amRNSPurchase of Own Shares
1st Apr 202212:02 pmRNSPurchase of Own Shares
31st Mar 202211:04 amRNSPurchase of Own Shares
30th Mar 20224:46 pmRNSDirector/PDMR Shareholding
30th Mar 202212:56 pmRNSPurchase of Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.